newsfilter
← Latest News
GlobeNewswire·

InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week

VANCOUVER, British Columbia, Oct. 26, 2022 (GLOBE NEWSWIRE) -- InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM), a leader in the research, development and manufacturing of rare cannabinoids, announces